Role of ATF4 in skeletal muscle atrophy

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 20, Issue 3, 2017, Pages 164-168

  Adams, Christopher M ^a,b,c   Ebert, Scott M ^a,b,c   Dyle, Michael C ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c Emmyon Inc   (United States)

Author keywords

aging; ATF4; Gadd45a; sarcopenia; skeletal muscle atrophy

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; GADD45A PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 4; OXIDOREDUCTASE; PROTEIN; PROTEIN P21; SPERMINE; SPERMINE OXIDASE; UNCLASSIFIED DRUG;

AGING; DIET RESTRICTION; ENZYME METABOLISM; HUMAN; IMMOBILIZATION; MUSCLE ATROPHY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SKELETAL MUSCLE; SKELETAL MUSCLE CELL; ANIMAL; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ACTIVATING TRANSCRIPTION FACTOR 4; AGING; ANIMALS; FASTING; HUMANS; IMMOBILIZATION; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUSCULAR ATROPHY; SIGNAL TRANSDUCTION;

EID: 85018427598     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000362     Document Type: Review

References (23)

1. Baird TD, Wek RC. Eukaryotic initiation factor 2 phosphorylation and translationalcontrol in metabolism. Adv Nutr 2012; 3:307-321.
2. Pakos-Zebrucka K, Koryga I, Mnich K, et al. The integrated stress response. EMBO Rep 2016; 17:1374-1395.
3. Ampofo E, Sokolowsky T, Gotz C, Montenarh M. Functional interaction ofprotein kinase CK2 and activating transcription factor 4 (ATF4), a key playerin the cellular stress response. Biochim Biophys Acta 2013; 1833:439-451.
4. Bagheri-Yarmand R, Sinha KM, Gururaj AE, et al. A novel dual kinase functionof the RET proto-oncogene negatively regulates activating transcription factor4-mediated apoptosis. J Biol Chem 2015; 290:11749-11761.
5. Mertins P, Qiao JW, Patel J, et al. Integrated proteomic analysis of posttranslationalmodifications by serial enrichment. NatMethods 2013; 10:634-637.
6. Sharma K, D'Souza RC, Tyanova S, et al. Ultradeep human phosphoproteomereveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. CellRep 2014; 8:1583-1594.
7. Mertins P, Yang F, Liu T, et al. Ischemia in tumors induces early and sustainedphosphorylation changes in stress kinase pathways but does not affect globalprotein levels. Mol Cell Proteomics 2014; 13:1690-1704.
8. KimW, Bennett EJ, Huttlin EL, et al. Systematic and quantitative assessmentof the ubiquitin-modified proteome. Mol Cell 2011; 44:325-340.
9. Hendriks IA, D'Souza RC, Yang B, et al. Uncovering global SUMOylationsignaling networks in a site-specific manner. Nat Struct Mol Biol 2014;21:927-936.
10. Reinke AW, Baek J, Ashenberg O, Keating AE. Networks of bZIP proteinproteininteractions diversified over a billion years of evolution. Science 2013;340:730-734.
11. Huggins CJ, Mayekar MK, Martin N, et al. C/EBPgamma is a critical regulatorof cellular stress response networks through heterodimerization with ATF4. Mol Cell Biol 2015; 36:693-713.
12. Adams CM, Ebert SM, Dyle MC. Use of mRNA expression signatures todiscover small molecule inhibitors of skeletal muscle atrophy. Curr Opin ClinNutr Metab Care 2015; 18:263-268.
13. Sacheck JM, Hyatt JP, Raffaello A, et al. Rapid disuse and denervation atrophyinvolve transcriptional changes similar to those of muscle wasting duringsystemic diseases. FASEB J 2007; 21:140-155.
14. Ebert SM, Monteys AM, Fox DK, et al. The transcription factor ATF4promotes skeletal myofiber atrophy during fasting. Mol Endocrinol 2010;24:790-799.
15. Ebert SM, Dyle MC, Kunkel SD, et al. Stress-induced skeletal muscleGadd45a expression reprograms myonuclei and causes muscle atrophy. J Biol Chem 2012; 287:27290-27301.
16. Fox DK, Ebert SM, Bongers KS, et al. p53 and ATF4 mediate distinct andadditive pathways to skeletal muscle atrophy during limb immobilization. Am JPhysiol Endocrinol Metab 2014; 307:E245-261.
17. Ebert SM, Dyle MC, Bullard SA, et al. Identification and small moleculeinhibition of an activating transcription factor 4 (ATF4)-dependent pathwayto age-related skeletal muscle weakness and atrophy. J Biol Chem 2015;290:25497-25511.
18. Miyake M, Nomura A, Ogura A, et al. Skeletal muscle-specific eukaryotictranslation initiation factor 2alpha phosphorylation controls amino acid metabolismand fibroblast growth factor 21-mediated noncell-autonomous energymetabolism. FASEB J 2016; 30:798-812.
19. Milan G, Romanello V, Pescatore F, et al. Regulation of autophagy and theubiquitin-proteasome system by the FoxO transcriptional network duringmuscle atrophy. Nat Comm 2015; 6:6670.
20. Bongers KS, Fox DK, Ebert SM, et al. Skeletal muscle denervationcauses skeletal muscle atrophy through a pathway that involves bothGadd45a and HDAC4. Am J Physiol Endocrinol Metab 2013; 305:E907-E915.
21. Salvador JM, Brown-Clay JD, Fornace AJ Jr. Gadd45 in stress signaling, cellcycle control, apoptosis. Adv Exp Med Biol 2013; 793:1-19.
22. Bullard SA, Seo S, Schilling B, et al. Gadd45a protein promotes skeletalmuscle atrophy by forming a complex with the protein kinase MEKK4. J BiolChem 2016; 291:17496-17509.
23. Bongers KS, Fox DK, Kunkel SD, et al. Spermine oxidase maintains basalskeletal muscle gene expression and fiber size and is strongly repressed byconditions that cause skeletal muscle atrophy. Am J Physiol Endocrinol Metab2015; 308:E144-E158.